| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2006 | EP1696895A1 Modulation of 5-ht2 receptors as a treatment for cardiovascular diseases |
| 09/06/2006 | EP1696894A1 Treating infectious diseases using ice inhibitors |
| 09/06/2006 | EP1696893A1 Continuous combination therapy with selective prostaglandin ep4, receptor agonists and an estrogen for the treatment of conditions that present with low bone mass. |
| 09/06/2006 | EP1696891A2 Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
| 09/06/2006 | EP1696890A2 Coated tablet containing venlafaxin or its salts with controlled release |
| 09/06/2006 | EP1696889A1 Pharmaceutical compositions of benzimidazole and processes for their preparation |
| 09/06/2006 | EP1696888A1 Process for producing pellets for pharmaceutical compositions |
| 09/06/2006 | EP1696887A1 Solid amorphous dispersions of an mtp inhibitor for treatment of obesity |
| 09/06/2006 | EP1696885A2 Method of producing lipid complexed camptothecin-carboxylate |
| 09/06/2006 | EP1696884A2 Loading of a camptothecin drug into colloidal nanoparticles |
| 09/06/2006 | EP1696881A2 Stable oral composition |
| 09/06/2006 | EP1696878A1 Ophthalmic compositions containing a polysaccharide/borate gelling system |
| 09/06/2006 | EP1696877A2 Methods for treating pain |
| 09/06/2006 | EP1696876A2 Buccal, polar and non-polar spray containing alprazolam |
| 09/06/2006 | EP1696874A1 Effervescent preparation of a basic medicinal substance |
| 09/06/2006 | EP1696859A2 Method for improving insulin sensitivity by administering an inhibitor of antitrypsin |
| 09/06/2006 | EP1696825A1 Use of alginate matrices to control cell growth |
| 09/06/2006 | EP1696741A1 Use of hydroxyoleic acid and related compounds as functional food additives |
| 09/06/2006 | EP1696737A1 Edible compositions which are adapted for use by a companion animal |
| 09/06/2006 | EP1608351B1 Compositions containing superoxide dismutase and a selected et 5-lipoxygenase inhibitor and uses thereof |
| 09/06/2006 | EP1562935B1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 09/06/2006 | EP1551378A4 Epo d + 5-fu/gemcitabine |
| 09/06/2006 | EP1525215B1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 09/06/2006 | EP1517894B1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 09/06/2006 | EP1510136B1 Process for producing lactulose-containing powder composition, lactulose-containing powder composition obtained by the process and feed additive |
| 09/06/2006 | EP1487836B1 Ethane-1,2-diamino-bis (2r)-2-bromo-3-phenylpropanoate|, method for production and use thereof |
| 09/06/2006 | EP1458697B1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 09/06/2006 | EP1458673B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 09/06/2006 | EP1453520B1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/06/2006 | EP1438042B1 Polymaleimide compounds and their medical use |
| 09/06/2006 | EP1436303B1 Pharmaceutically acceptable alendronate salts in amorphous form |
| 09/06/2006 | EP1423357B1 Urea derivatives with antiproteolytic activity |
| 09/06/2006 | EP1420771B1 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases |
| 09/06/2006 | EP1409490B1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta a|naphthalenyl derivatives with antipsychotic activity |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1401814B1 Derivatives of 3-phenyl-n-(2- (4-benzyl) piperidin-1-yl)-ethyl)-acrylamid with ccr-3 receptor antagonistic activity for use in the treatment of inflammations and allergic conditions |
| 09/06/2006 | EP1401441A4 Allosteric adenosine receptor modulators |
| 09/06/2006 | EP1401275B1 Antiviral composition and treatment method |
| 09/06/2006 | EP1397145B1 Use of cox-2 inhibitors for the treatment of schizophrenia, or tic disorders |
| 09/06/2006 | EP1385513B1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents |
| 09/06/2006 | EP1383768B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/06/2006 | EP1374952B1 Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 09/06/2006 | EP1360222B1 Organopolysiloxanes containing phosphonic groups, methods for the production and use thereof |
| 09/06/2006 | EP1359921A4 Methods to treat autoimmune and inflammatory conditions |
| 09/06/2006 | EP1349553B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 09/06/2006 | EP1345607B1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 09/06/2006 | EP1341517B1 A skin cream composition |
| 09/06/2006 | EP1326632B1 Proteasome inhibitors for the treatment of hepatitis virus infections |
| 09/06/2006 | EP1303308B1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 09/06/2006 | EP1286652B1 Skin protectant spray compositions |
| 09/06/2006 | EP1274423A4 Medicine for treating traumatic brain injury and other neuronal disorders |
| 09/06/2006 | EP1259241B8 The use of scopolamine salts |
| 09/06/2006 | EP1253909B1 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 09/06/2006 | EP1227780A4 A stable aqueous dispersion of nutrients |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | EP1176964B1 Uses of et743 for treating cancer |
| 09/06/2006 | EP1173224B1 Polyethyleneimine:dna formulations for aerosol delivery |
| 09/06/2006 | EP1135374B1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/06/2006 | EP1131081A4 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway |
| 09/06/2006 | EP1112075B1 Compositions for the treatment of male erectile dysfunction |
| 09/06/2006 | EP1071449B1 Use of an antagonist antibody to the inflammatory mediator oncostatin m (osm) |
| 09/06/2006 | EP1023435B1 Novel lactic acid bacteria species |
| 09/06/2006 | EP1014990B1 Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum |
| 09/06/2006 | EP1009388A4 Sustained release drug delivery devices |
| 09/06/2006 | EP0881912A4 Use of angiogenic lipids for vascularizing tissue |
| 09/06/2006 | EP0832232B9 Kunitz type plasma kallikrein inhibitors |
| 09/06/2006 | EP0815204B1 Method for treating tumors by alloactivated human donor lymphocytes |
| 09/06/2006 | EP0781137B1 Use of phosphoglycerides comprising phosphoglycero ethers for treating neurodegenerative diseases in mentally severe handicapped children |
| 09/06/2006 | CN1829804A Target for therapy of cognitive impairment |
| 09/06/2006 | CN1829743A Complex matrix for biomedical use |
| 09/06/2006 | CN1829741A Treatment with anti-VEGF antibodies |
| 09/06/2006 | CN1829731A Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof |
| 09/06/2006 | CN1829729A 新颖化合物 Novel compounds |
| 09/06/2006 | CN1829728A 新颖化合物 Novel compounds |
| 09/06/2006 | CN1829727A High viscosity xanthan polymer preparations |
| 09/06/2006 | CN1829721A Spiro '1-azabicyclo' 2.2.2! octan-3,5'-oxazolidin - 2'-one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor |
| 09/06/2006 | CN1829720A 7-substituted 3-nitro-pyrazolo '1,5-a! pyrimidines |
| 09/06/2006 | CN1829719A N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto |
| 09/06/2006 | CN1829718A Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 09/06/2006 | CN1829715A Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
| 09/06/2006 | CN1829714A Pna单体和前体 Pna monomers and precursors |
| 09/06/2006 | CN1829713A 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 09/06/2006 | CN1829712A Nicotinamide derivatives useful as PDE4 inhibitors |
| 09/06/2006 | CN1829711A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829709A Bicyclic imidazol derivatives against flaviviridae |
| 09/06/2006 | CN1829708A Piperidine compounds and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829704A Benzo [1,2,5] thiadiazole compounds as CCK2 modulators |
| 09/06/2006 | CN1829703A (Thio)carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 09/06/2006 | CN1829701A Piperazine derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829699A Pyridazinyl- piperazines and their use as histamine h3 receptor |
| 09/06/2006 | CN1829698A Pyridazine derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof |
| 09/06/2006 | CN1829695A Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/06/2006 | CN1829694A Quinoline derivates and their use in therapy |
| 09/06/2006 | CN1829693A Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same |
| 09/06/2006 | CN1829691A Pyridyl derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829690A Pyridyl derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829689A Benzylamine derivative |
| 09/06/2006 | CN1829684A 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives |
| 09/06/2006 | CN1829683A Mildronate salt and its preparation method, and pharmaceutical composition based on mildronate |